These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 27595116)
1. Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma. Lu Z; Peng K; Wang N; Liu HM; Hou G J Immunol Res; 2016; 2016():7828916. PubMed ID: 27595116 [TBL] [Abstract][Full Text] [Related]
2. [Sensitivity of esophageal squamous cell carcinoma cells to rapamycin can be improved by siRNA-interfered expression of p70S6K]. Liu M; Lu Z; Zheng Y; Cui Y; Wang J; Hou G Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):885-9. PubMed ID: 26887615 [TBL] [Abstract][Full Text] [Related]
3. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Hou G; Xue L; Lu Z; Fan T; Tian F; Xue Y Cancer Lett; 2007 Aug; 253(2):236-48. PubMed ID: 17360108 [TBL] [Abstract][Full Text] [Related]
4. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma. Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma. Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316 [TBL] [Abstract][Full Text] [Related]
6. Wild-type phosphatase and tensin homolog deleted on chromosome 10 improved the sensitivity of cells to rapamycin through regulating phosphorylation of Akt in esophageal squamous cell carcinoma. Lu Z; Wang J; Zheng Y; Yang S; Liu M; Chen X; Wang C; Hou G Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26725440 [TBL] [Abstract][Full Text] [Related]
7. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice]. Liu MY; Hou GQ; Zhang Y; Bei WJ; Yan AH Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):334-9. PubMed ID: 21875460 [TBL] [Abstract][Full Text] [Related]
8. Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro. Li Q; Yang L; Han K; Zhu L; Zhang Y; Ma S; Zhang K; Yang B; Guan F Oncotarget; 2016 Sep; 7(38):61458-61468. PubMed ID: 27556183 [TBL] [Abstract][Full Text] [Related]
9. Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice. Liu Y; Wang X; Jia Y; Liu Y Int J Mol Med; 2017 Aug; 40(2):357-366. PubMed ID: 28656204 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977 [TBL] [Abstract][Full Text] [Related]
11. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE Pun IH; Chan D; Chan SH; Chung PY; Zhou YY; Law S; Lam AK; Chui CH; Chan AS; Lam KH; Tang JC Cancer Res Treat; 2017 Jan; 49(1):219-229. PubMed ID: 27456944 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496 [TBL] [Abstract][Full Text] [Related]
13. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro]. Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222 [TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of mTOR signaling improves sensitivity of esophageal squamous cell carcinoma cells to cisplatin. Hou G; Yang S; Zhou Y; Wang C; Zhao W; Lu Z J Immunol Res; 2014; 2014():845763. PubMed ID: 24818169 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
16. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation. Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma. Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233 [TBL] [Abstract][Full Text] [Related]
18. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. Wang F; Ding X; Wang T; Shan Z; Wang J; Wu S; Chi Y; Zhang Y; Lv Z; Wang L; Fan Q PLoS One; 2017; 12(4):e0174276. PubMed ID: 28406985 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of frizzled-7 inhibits cell growth and metastasis and promotes chemosensitivity of esophageal squamous cell carcinoma cells by inhibiting Wnt signaling. Liu X; Yan Y; Ma W; Wu S Biochem Biophys Res Commun; 2017 Aug; 490(3):1112-1118. PubMed ID: 28669726 [TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma. Gong F; Hou G; Liu H; Zhang M Med Oncol; 2015 Feb; 32(2):455. PubMed ID: 25579166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]